Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Actavis Inc    

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Watson Pharmaceuticals, Inc. : Watson to Present at the Bank of America Merrill Lynch 2012 Health Care Conference

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/04/2012 | 10:05pm CEST

PARSIPPANY, N.J., May 4, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty global pharmaceutical company, announced today that Paul Bisaro, Watson's President and Chief Executive Officer, will provide an overview and update of the Company's business at the Bank of America Merrill Lynch 2012 Healthcare Conference on Wednesday, May 16, 2012 at 10:00 AM Pacific Time at the Encore at the Wynn in Las Vegas, Nevada. The presentation will be webcast live and can be accessed on Watson Pharmaceuticals' Investor Relations Website at http://ir.watson.com. The webcast can also be accessed at the following URL: http://www.veracast.com/webcasts/baml/healthcare2012/id16635640.cfm

An archived version will be available approximately one hour after the live presentation ends and can be accessed at the same locations for 90 days.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc. is an integrated global specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health. The Company is also developing biosimilar products in Women's Health and Oncology. Additionally, Watson distributes generic and branded pharmaceuticals through its Anda, Inc. distribution business. Watson has operations in many of the worlds established and growing international markets.

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

    CONTACTS:                         Investors:
                                      Lisa DeFrancesco
                                      (862) 261-7152

                                      Media:
                                      Charlie Mayr
                                      (862) 261-8030

(Photo: http://photos.prnewswire.com/prnh/20100121/LA41294LOGO)

SOURCE Watson Pharmaceuticals, Inc.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ACTAVIS INC
08/30 U.S. slams EU, but Apple tax demand first issued in Washington
08/29DJMondelez Walks Away After Hershey Spurns Raised Bid
08/24DJPfizer Buys Part of AstraZeneca's Antibiotics Business
08/09DJBotox Maker Allergan's Revenue Climbs, but Loss More Than Doubles -- WSJ
08/08DJAllergan Revenue Increases, Though Loss Widens--Update
08/08DJMARKET SNAPSHOT : Stocks Back Off All-time Highs As Health-care Stocks Slump
08/08DJMARKET SNAPSHOT : Stocks Retreat From Records As Health-care Stocks Slump
08/08DJU.S. Stocks Slip Despite Surge in Energy Sector
08/05DJPFIZER : Business Groups Sue Over Inversion Rules -- WSJ
08/04DJPFIZER : Business Groups Sue U.S. Government Over Tax-Inversion Rules -- 2nd Upd..
More news
Sector news : Pharmaceuticals - NEC
12:33a ASTRAZENECA : to pay $5.52 million to resolve U.S. SEC foreign bribery case
08/30 U.S. slams EU, but Apple tax demand first issued in Washington
08/30DJNOVARTIS : FDA Approves Novartis's Biosimilar to Amgen's Enbrel
08/30DJFertilizer Producers Agrium and Potash in Merger Talks
08/30DJOrexigen in Canadian Marketing Pact With Valeant for Diet Drug
More sector news : Pharmaceuticals - NEC